GSTM1 and neoplasm: This Hb-egf mutant cell line produced tumors in both genetic backgrounds, but the pericyte coverage of the tumor neovasculature was decreased by ~24% in tumors recovered from Hb-egf mutant hosts compared to tumors recovered from wild-type hosts (Fig. 8D).